From Nasdaq: 2024-12-20 16:00:00

Anavex Life Sciences Corp. (AVXL) is set to report earnings for the quarter ending September 30, 2024. The consensus earnings per share forecast is $-0.17, a 41.67% decrease from the same quarter last year. AVXL has met analyst expectations once and exceeded them three times in the past year. The stock has a “days to cover” metric exceeding 12 days.

Zacks Investment Research reports that AVXL has a 2024 Price to Earnings ratio of -15.40, compared to an industry ratio of -1.30. The company’s performance will be closely watched by investors and analysts. Check the Earnings Calendar for more updates on expected earnings releases prior to market open on 12/23/2024.



Read more at Nasdaq:: Pre-Market Earnings Report for December 23, 2024 : AVXL